Pre-market · Oct 8, 8:20 am ET · After hours $12.77 0.00%
Open$13.00
Prev close$13.10
Day range$12.75 – $13.36
Volume365.2K
Market cap$872.26M
P/E (TTM)16.4
Dividend yield–
BVS Stock News
Headlines matching Bioventus or the BVS ticker, most recent first.
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15Market news · 6 Aug 2026 · Direct mention
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18PositiveMarket news · 6 Aug 2026 · Direct mention
Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18PositiveMarket news · 6 Aug 2026 · Direct mention
Earnings Flash (BVS) Bioventus Inc. Posts Q2 Adjusted EPS $0.22 per Share, Vs. FactSet Est of $0.22MT Newswires · 5 Aug 2026 · Direct mention
J.P. Morgan Keeps Their Hold Rating on Bravura Solutions Limited (BVS)TipRanks · 17 Aug 2026 · Direct mention
CCORF Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $19Market news · 17 Aug 2026 · Direct mention
Analysts Have Conflicting Sentiments on These Healthcare Companies: Atai Beckley N.V. (ATAI), Bioventus (BVS) and Crinetics Pharmaceuticals (CRNX)TipRanks · 7 Jul 2026 · Direct mention
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $16Market news · 7 Jul 2026 · Direct mention
Barrington Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $14Market news · 6 Jul 2026 · Direct mention
Craig-Hallum Maintains Bioventus(BVS.US) With Buy RatingMarket news · 24 May 2026 · Direct mention
Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $14PositiveMarket news · 6 Mar 2026 · Direct mention
CJS Securities Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $14Market news · 27 Mar 2026 · Direct mention
Barrington Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $13Market news · 9 Feb 2026 · Direct mention
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $15Market news · 7 Aug 2025 · Direct mention
TR | OpenAI - 4o Maintains Bioventus(BVS.US) With Hold Rating, Raises Target Price to $8PositiveMarket news · 24 Aug 2025 · Direct mention
Discussion
No comments yet — be the first to weigh in on BVS.
No comments yet — be the first to weigh in on BVS.